News for 'Post Sun Pharma'

MF GURU: 'Invest VRS money in MFs?'

MF GURU: 'Invest VRS money in MFs?'

Rediff.com30 Aug 2022

Omkeshwar Singh, Head, Rank MF, a mutual fund investment platform, answers your queries.

'Is investing in gold, govt bonds better than stocks?'

'Is investing in gold, govt bonds better than stocks?'

Rediff.com23 Oct 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex drops 129 points; Reliance tumbles 2%

Sensex drops 129 points; Reliance tumbles 2%

Rediff.com31 Jul 2020

HDFC Bank, Asian Paints, Kotak Bank, Bajaj Auto and HDFC were among the other laggards.

ASK AJIT: Are these stocks good to hold for one year?

ASK AJIT: Are these stocks good to hold for one year?

Rediff.com1 Sep 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Govt in talks with Pfizer, J&J for supply of vaccines to India

Govt in talks with Pfizer, J&J for supply of vaccines to India

Rediff.com2 Jun 2021

The central government is importing COVID-19 vaccines and is in talks with COVID-19 vaccine manufacturers Pfizer and Johnson & Johnson, Union Minister of State for Home Affairs G Kishan Reddy said.

Hiring activities improve by 24% in Sep : Report

Hiring activities improve by 24% in Sep : Report

Rediff.com12 Oct 2020

With life returning to normalcy gradually, hiring activities grew 24 per cent in September as compared to the previous month mostly driven by pharmaceutical and education sectors, according to a report. At 1,755 job postings, there was an improvement of 24 per cent in hiring activities last month compared to August with 1,413 listings, according to the Naukri JobSpeak Index for September 2020

Making losses in stocks? Here's help

Making losses in stocks? Here's help

Rediff.com21 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries

Sensex sinks 2,002 pts as global selloff intensifies

Sensex sinks 2,002 pts as global selloff intensifies

Rediff.com4 May 2020

ICICI Bank was the top laggard in the Sensex pack, sinking over 10 per cent, followed by Bajaj Finance, HDFC, IndusInd Bank, Axis Bank and Maruti. Bharti Airtel and Sun Pharma were the gainers in the BSE index. NSE Nifty suffered a heavy loss of 566.40 points, or 5.74 per cent, to settle at 9,293.50.

MF GURU: 'Want to invest Rs 2.5 lakhs'

MF GURU: 'Want to invest Rs 2.5 lakhs'

Rediff.com7 Dec 2021

Omkeshwar Singh, head, Rank MF, a mutual fund investment platform, answers your queries.

Exports, imports fall, but trade turns surplus after 18 years

Exports, imports fall, but trade turns surplus after 18 years

Rediff.com15 Jul 2020

Import segments which recorded negative growth include gold, silver, transport equipment, coal, fertiliser, machinery and machine tools. However, exports of oil seeds, coffee, rice, tobacco, spices, pharma, and chemicals reported positive growth in June.

Sun Pharma FY04 consolidated net up 45%

Sun Pharma FY04 consolidated net up 45%

Rediff.com22 Apr 2004

Sun Pharmaceuticals Industries Ltd has posted a 45.01 per cent rise in its consolidated net profit at Rs 358.9 crore (Rs 3.59 billion) for the financial year 2003-04 as against Rs 247.5 crore (Rs 2.47 billion) in 2002-03.

2 volunteers who were given Oxford vaccine doing fine

2 volunteers who were given Oxford vaccine doing fine

Rediff.com27 Aug 2020

Two men, aged 32 and 48, were given the first shot of the 'Covishield' vaccine, being manufactured by Pune-based Serum Institute of India, at Bharti Vidyapeeth's Medical College and Hospital on Wednesday. The dose will be repeated after one month, an official said.

Govt approves 2 new vaccines, Covid drug for emergency use

Govt approves 2 new vaccines, Covid drug for emergency use

Rediff.com28 Dec 2021

The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the CDSCO recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.

Pfizer withdraws emergency use for its Covid vaccine in India

Pfizer withdraws emergency use for its Covid vaccine in India

Rediff.com5 Feb 2021

An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage just two days ago, officials said.

Markets end flat; Nifty hovers around 7,850

Markets end flat; Nifty hovers around 7,850

Rediff.com29 Apr 2016

ICICI Bank was the top loser after the private lender reported sharp drop in Q4 net.

'Profiting from Pain': Covid created new billionaire every 30 hrs

'Profiting from Pain': Covid created new billionaire every 30 hrs

Rediff.com23 May 2022

Releasing a report titled 'Profiting from Pain' in Davos, the rights group further said as the cost of essential goods rises faster than it has in decades, billionaires in the food and energy sectors are increasing their fortunes by $1 billion every two days.

Dilution norms for large IPOs tweaked

Dilution norms for large IPOs tweaked

Rediff.com21 Jun 2021

Easier dilution norms for mega initial public offerings (IPOs) have come into effect. Companies with post-listing market capitalisation (m-cap) of more than Rs 1 trillion will not be required to dilute a minimum of 10 per cent. The move to relax dilution norms is seen as a precursor to Life Insurance Corporation's IPO. The central government has said companies with an m-cap exceeding Rs 1 trillion will have to dilute Rs 5,000 crore and at least 5 per cent of their m-cap. Experts said the earlier framework discouraged large companies from listing since they were forced to offload a large volume of shares during the time of their IPO.

Sensex falls 97 pts, Nifty below 8,700 post RBI policy review

Sensex falls 97 pts, Nifty below 8,700 post RBI policy review

Rediff.com9 Aug 2016

Sectoral performance was mixed with media and PSU banking stocks attracting buyer interest and healthcare, FMCG and metal stocks bearing the brunt of the bears

'Reversal of IPO frenzy is taking longer than in the past'

'Reversal of IPO frenzy is taking longer than in the past'

Rediff.com9 Apr 2021

'Investors should be careful in getting carried away; although a reversal of IPO frenzy this time is taking longer than in the past.'

Twitter deliberately chose path of non-compliance: Prasad

Twitter deliberately chose path of non-compliance: Prasad

Rediff.com16 Jun 2021

Lashing out at the micro-blogging platform over non-compliance, Prasad said that it is "astounding" that Twitter that portrays itself as the flag bearer of free speech, chooses the path of deliberate defiance when it comes to the intermediary guidelines.

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

Business travel takes off again on a wing and a prayer

Business travel takes off again on a wing and a prayer

Rediff.com2 Nov 2021

Business executives are finally dusting off their long-unused suitcases to resume travel, thanks to a good vaccination rate, a drop in fresh cases, and an easing of travel restrictions. It comes as a huge relief for the ravaged aviation, travel and hospitality sectors. "We are witnessing a 40 per cent recovery on pre-covid volumes from our business travellers, signalling the return of corporate confidence in air travel," said Indiver Rastogi, president & group head, Global Business Travel, Thomas Cook (India) & SOTC.

'Definite improvement in economic activity in October'

'Definite improvement in economic activity in October'

Rediff.com24 Nov 2021

'I hope the trend is sustainable and that economic activity accelerates going forward.'

ASK AJIT: 'This stock hits circuits often. What to do?'

ASK AJIT: 'This stock hits circuits often. What to do?'

Rediff.com29 Mar 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex rallies 617 points to close above 51K-mark

Sensex rallies 617 points to close above 51K-mark

Rediff.com8 Feb 2021

M&M was the top gainer in the Sensex pack, soaring around 7 per cent, followed by Bajaj Finserv, Bharti Airtel, PowerGrid, Infosys and ICICI Bank. On the other hand, HUL, Kotak Bank, Bajaj Finance and ITC were among the laggards.

Ask Ajit: 'Bought shares at peak; please advice'

Ask Ajit: 'Bought shares at peak; please advice'

Rediff.com30 Mar 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Dilip Shanghvi's wealth creation machine

Dilip Shanghvi's wealth creation machine

Rediff.com7 Mar 2015

Sun Pharma stock has appreciated at 35% a year for 20 years

Sensex soars 537 points; Nifty reclaims 11,400-mark

Sensex soars 537 points; Nifty reclaims 11,400-mark

Rediff.com17 May 2019

In the Sensex pack, Bajaj Finance and Bajaj Auto ended up to 6.09 per cent higher after posting strong quarterly numbers.

Sensex jumps 260 points on gains in index majors

Sensex jumps 260 points on gains in index majors

Rediff.com15 Apr 2021

TCS was the top gainer in the Sensex pack, rising around 4 per cent, followed by ONGC, ICICI Bank, HDFC Bank, Dr Reddy's, HDFC and HCL Tech. NSE Nifty advanced 76.65 points to 14,581.45.

Coronavirus crisis pushes India to work on drug security

Coronavirus crisis pushes India to work on drug security

Rediff.com26 Mar 2020

The current crisis has forced the government to announce measures to ensure that India becomes self-sustaining for any kind of bulk drug. The government says India will not depend on any other country for vital key ingredients for drugs within six years, reports Sheela Bhatt.

New India can achieve difficult targets: PM on 1bn jabs feat

New India can achieve difficult targets: PM on 1bn jabs feat

Rediff.com22 Oct 2021

"It is a matter of pride for us that India's vaccination programme has been science-born, science-driven and science-based," Modi said.

Which stocks are there in Rakesh Jhunjhunwala's basket?

Which stocks are there in Rakesh Jhunjhunwala's basket?

Rediff.com13 Jan 2021

Jhunjhunwala holds a stake in more than 30 listed firms.

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Rediff.com19 Jul 2021

So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.

Dilip Shanghvi moves into top gear to turn around Ranbaxy

Dilip Shanghvi moves into top gear to turn around Ranbaxy

Rediff.com31 Jul 2015

Sun Pharma expects synergy benefits by next fiscal.

Top 7 cos add Rs 45,025 cr to market valuation

Top 7 cos add Rs 45,025 cr to market valuation

Rediff.com14 Aug 2016

TCS emerged as the biggest gainer among the top-10 firms

India imposes tit-for-tat Covid curbs on UK nationals

India imposes tit-for-tat Covid curbs on UK nationals

Rediff.com2 Oct 2021

British nationals arriving in India, irrespective of their vaccination status, will have to undergo 10 days of mandatory quarantine from October 4 as part of the reciprocal actions initiated by the government following the vaccine certification row between the two countries.

BSE: Top gainers and losers

BSE: Top gainers and losers

Rediff.com20 Jul 2016

Sentiment also remained buoyant as a good monsoon season lifted hopes of a revival in farm output.

Price relief for diabetes patients as drugs go off patent

Price relief for diabetes patients as drugs go off patent

Rediff.com13 Jan 2020

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.

MFs To Help Achieve Your Family Goals

MFs To Help Achieve Your Family Goals

Rediff.com15 Feb 2022

Omkeshwar Singh, head, Rank MF, a mutual fund investment platform, answers your queries.

Sensex tumbles 141 pts, Nifty by 48 pts

Sensex tumbles 141 pts, Nifty by 48 pts

Rediff.com7 Oct 2019

After swinging 439 points during the day, the 30-share Sensex ended 141.33 points, or 0.38 per cent, lower at 37,531.98. It hit an intra-day low of 37,480.53 and a high of 37,919.47.